Renaissance einer vergessenen Methode – Kapillar mikroskopie als wesentliches Element in der Diagnosefindung einer Overlap-Erkrankung

• Literatur

• 1 Wedderburn LR, Mc Hugh NJ. et al. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap. Rheumatology 2007; 46: 1786-1791.
• 2 Cutolo M. et al. Capillaroscopy and rheumatic diseases: state of the art. Z Rheumatol 2006; 65: 290-296.
• 3 Zulian F, Woo P. et al. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 2007; 57 (02) 203-212.
• 4 Richter J, Iking-Konert C. et al. Kapillarmikroskopie. Z Rheumatol 2013; 72: 145-150.
• 5 Sander O. Was kann die Kapillaroskopie leisten?. Internist Prax 2013; 53: 1-17.
• 6 Sander O, Sunderkötter C. et al. Kapillarmikroskopie. Durchführung und Nomenklatur. Z Rheumatol 2010; 69: 253-262.
• 7 Smith V, Riccieri V. et al. Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis. J Rheumatol 2013; 40 (12) 2023-2028.
• 8 Blaszczyk M, Jablonska S. Childhood scleromyositis: an overlap syndrome associated with Pm-Scl antibody. Pediatric Dermatol 1991; 8 (01) 1-8.
• 9 Piotto DG, Len CA. et al. Naifold capillaroscopy in children and adolescents with rheumatic diseases. Rev Bras Reumatol 2012; 52 (05) 722-732.
• 10 Piotto DG, Hilario MO. et al. Prospective nailfold capillaroscopy evaluation of Raynaud’s phenomenon in children and adolescents. Acta Reumatol Port 2013; 38: 114-121.